title: An immune-based assay for HIV disease management.
abstract: Today, patients infected with HIV are monitored routinely for their levels of CD4+ T cells and viral load. Since either or both of these parameters are often discordant with the clinical course, the direct measurement of immune function to more accurately reflect clinical status is needed (Figure 3). The in vitro CMI test provides a rapid method for assessing cell-mediated immunity and is an important adjunct to the clinical management of these patients.
authors.affiliation: Cylex Inc., 8980-I Old Annapolis Rd., Columbia, MD 21045, USA. rkowalski@cylex.net
authors.forename: R
authors.initials: R
authors.lastname: Kowalski
authors.forename: J
authors.initials: J
authors.lastname: Woodcock
authors.forename: P
authors.initials: P
authors.lastname: Sottong
authors.forename: J A
authors.initials: JA
authors.lastname: Britz
mesh_terms: D015415:Biomarkers; D015658:HIV Infections / Q000175:diagnosis* / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular
chemical_list: D015415:Biomarkers